Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 2
1969 2
1972 1
1973 1
1974 1
1975 2
1976 2
1977 6
1978 7
1979 7
1980 15
1981 9
1982 16
1983 21
1984 12
1985 10
1986 18
1987 20
1988 33
1989 21
1990 32
1991 45
1992 54
1993 83
1994 44
1995 69
1996 106
1997 80
1998 138
1999 137
2000 141
2001 129
2002 125
2003 138
2004 107
2005 113
2006 96
2007 113
2008 83
2009 75
2010 89
2011 98
2012 114
2013 101
2014 106
2015 108
2016 86
2017 81
2018 94
2019 114
2020 111
2021 123
2022 122
2023 93
2024 94
2025 90
2026 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,548 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Erythromycin Improves the Quality of Esophagogastroduodenoscopy in Upper Gastrointestinal Bleeding: A Network Meta-Analysis.
Aziz M, Haghbin H, Gangwani MK, Weissman S, Patel AR, Randhawa MK, Samikanu LB, Alyousif ZA, Lee-Smith W, Kamal F, Nawras A, Howden CW. Aziz M, et al. Dig Dis Sci. 2023 Apr;68(4):1435-1446. doi: 10.1007/s10620-022-07698-z. Epub 2022 Sep 16. Dig Dis Sci. 2023. PMID: 36112271
RESULTS: We included eight RCTs with four distinct intervention groups (erythromycin, placebo to erythromycin, nasogastric (NG) lavage and NG lavage + erythromycin) published between 2002 and 2020 with a total of 721 patients (mean age 60.0 3.1 years; 73.2% …
RESULTS: We included eight RCTs with four distinct intervention groups (erythromycin, placebo to erythromycin, nasogastric (NG …
Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis.
Seaman RD, Kopkin RH, Turrentine MA. Seaman RD, et al. Am J Obstet Gynecol. 2022 Jun;226(6):794-801.e1. doi: 10.1016/j.ajog.2021.12.262. Epub 2021 Dec 29. Am J Obstet Gynecol. 2022. PMID: 34973176
The median point prevalence rates of clinical chorioamnionitis were 25% (95% confidence interval, 12-32) in women treated with erythromycin and 14% (95% confidence interval, 9-24) in women treated with azithromycin. The overall clinical chorioamnionitis rate in women treat …
The median point prevalence rates of clinical chorioamnionitis were 25% (95% confidence interval, 12-32) in women treated with erythromyc …
Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Ashy N, Alharbi L, Alkhamisi R, Alradadi R, Eljaaly K. Ashy N, et al. J Infect Chemother. 2022 Aug;28(8):1148-1152. doi: 10.1016/j.jiac.2022.04.020. Epub 2022 May 3. J Infect Chemother. 2022. PMID: 35523718
RESULTS: We included four RCTs (total of 472 patients), which compared the clinical efficacy of erythromycin versus clarithromycin. No studies comparing monotherapy of erythromycin versus azithromycin were found. ...CONCLUSION: Erythromycin is less effective …
RESULTS: We included four RCTs (total of 472 patients), which compared the clinical efficacy of erythromycin versus clarithromycin. N …
Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
Ng E, Shah VS. Ng E, et al. Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD001815. doi: 10.1002/14651858.CD001815.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646077 Free PMC article.
However, a significant number of studies using erythromycin at a higher dose (> 12 mg/kg/day) or as prophylaxis for those at risk of feeding intolerance were identified. ...AUTHORS' CONCLUSIONS: There is insufficient evidence to recommend the use of erythromycin …
However, a significant number of studies using erythromycin at a higher dose (> 12 mg/kg/day) or as prophylaxis for those at risk …
[Erythromycin for improving enteral nutrition tolerance in adult critical patients: a systematic review and meta-analysis].
Luan R, Tang H, Zhai S, Zhu X. Luan R, et al. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jun;26(6):425-30. doi: 10.3760/cma.j.issn.2095-4352.2014.06.012. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014. PMID: 24912643 Chinese.
Ten RCTs involving 668 patients were included for evaluating erythromycin in improving EN tolerance. Six RCTs involving 353 patients were included for evaluating erythromycin to increase the successful rate of postpyloric EN tube. ...There was no statistic differenc …
Ten RCTs involving 668 patients were included for evaluating erythromycin in improving EN tolerance. Six RCTs involving 353 patients …
Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis.
Szary NM, Gupta R, Choudhary A, Matteson ML, Arif M, Hammad HT, Bechtold ML. Szary NM, et al. Scand J Gastroenterol. 2011 Jul;46(7-8):920-4. doi: 10.3109/00365521.2011.568520. Epub 2011 May 11. Scand J Gastroenterol. 2011. PMID: 21561232

RESULTS: Four studies (N = 269) met the inclusion criteria. Erythromycin prior to endoscopy in UGIB demonstrated a statistically significant improvement in visualization of the gastric mucosa (OR 4.89; 95% CI 2.85-8.38, p < 0.01), a decrease in the need for a second end

…
RESULTS: Four studies (N = 269) met the inclusion criteria. Erythromycin prior to endoscopy in UGIB demonstrated a statistically sign …
Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
Li W, Qin Z, Gao J, Jiang Z, Chai Y, Guan L, Chen Y. Li W, et al. Chron Respir Dis. 2019 Jan-Dec;16:1479972318790269. doi: 10.1177/1479972318790269. Epub 2018 Aug 12. Chron Respir Dis. 2019. PMID: 30101613 Free PMC article.
The AITC showed that azithromycin had a significantly lower bronchiectasis exacerbation rate than erythromycin (RR = 0.35; 95% CI: 0.403-0.947). Azithromycin increased the risk of diarrhea and abnormal pain. ...Moreover, azithromycin is more efficient than roxithromycin an …
The AITC showed that azithromycin had a significantly lower bronchiectasis exacerbation rate than erythromycin (RR = 0.35; 95% CI: 0. …
Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
Murchison L, De Coppi P, Eaton S. Murchison L, et al. Pediatr Surg Int. 2016 Dec;32(12):1147-1152. doi: 10.1007/s00383-016-3971-5. Epub 2016 Sep 21. Pediatr Surg Int. 2016. PMID: 27655365 Free PMC article.
PURPOSE: Macrolide antibiotics, erythromycin, in particular, have been linked to the development of infantile hypertrophic pyloric stenosis (IHPS). Our aim was to conduct a systematic review of the evidence of whether post-natal erythromycin exposure is associated w …
PURPOSE: Macrolide antibiotics, erythromycin, in particular, have been linked to the development of infantile hypertrophic pyloric st …
Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis.
Turrentine MA, Newton ER. Turrentine MA, et al. Obstet Gynecol. 1995 Dec;86(6):1021-5. doi: 10.1016/0029-7844(95)00296-4. Obstet Gynecol. 1995. PMID: 7501326
The pooled RR for the effectiveness of amoxicillin compared with erythromycin was 1.11 (95% confidence interval [CI] 1.05-1.18), and the pooled RR for gastrointestinal side effects of amoxicillin compared with erythromycin was 0.29 (95% CI 0.20-0.42). The pooled RR …
The pooled RR for the effectiveness of amoxicillin compared with erythromycin was 1.11 (95% confidence interval [CI] 1.05-1.18), and …
Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding.
Bai Y, Guo JF, Li ZS. Bai Y, et al. Aliment Pharmacol Ther. 2011 Jul;34(2):166-71. doi: 10.1111/j.1365-2036.2011.04708.x. Epub 2011 May 25. Aliment Pharmacol Ther. 2011. PMID: 21615438
BACKGROUND: Studies evaluating the effect of erythromycin on patients with acute upper gastrointestinal bleeding (UGIB) had been reported, but the results were inconclusive. AIMS: To compare erythromycin with control in patients with acute UGIB by performing a meta- …
BACKGROUND: Studies evaluating the effect of erythromycin on patients with acute upper gastrointestinal bleeding (UGIB) had been repo …
3,548 results